. 2020 Dec 23;13(1):12. doi: 10.3390/pharmaceutics13010012

Table 6.

Adverse events reported during the study.

System Organ Classification/ Preferred Term (PT)	Reported Incidence by Treatment Group
System Organ Classification/ Preferred Term (PT)	MTK Film (N = 8)	MTK Tablet (N = 8)
Nervous System Disorders
Somnolence	2 (25.0%))	0 (0.0%)
Headache	1 (12.5%)	0 (0.0%)
Skin and Subcutaneous Tissue Disorders
Pruritus	1 (12.5%)	0 (0.0%)
Mechanical urticaria	1 (12.5%)	0 (0.0%)
Musculoskeletal and Connective Tissue Disorders
Back pain	1 (12.5%)	0 (0.0%)
Total	6 (75.0%)	0 (0.0%)

MTK Film: Montelukast 10 mg Oral Film; Lot No: 16E-MOT010-0001, by IntelGenx Corp. MTK Tablet: Singulair^® 10 mg Tablets; Lot No: L044452, by Merck Sharp & Dohme Ltd., Hertfordshire, UK.